Sarecka-Hujar Beata, Kopyta Ilona, Skrzypek Michal, Sordyl Joanna
Department of Pharmaceutical Technology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
Department of Paediatric Neurology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Katowice, Poland.
Pediatr Neurol. 2017 Apr;69:93-101. doi: 10.1016/j.pediatrneurol.2016.12.013. Epub 2017 Jan 4.
Previous data have shown that the 20210G>A polymorphism of the Factor II gene is related to an increased prothrombin level, which may in turn lead to a procoagulant state. The heterogeneous and multifactorial character of arterial ischemic stroke often results in contradictory reports describing the association between the 20210G>A polymorphism and arterial ischemic stroke in different populations. We performed a meta-analysis of available data addressing the relation between the FII 20210G>A polymorphism and arterial ischemic stroke, both in young adults and children.
We searched PubMed using appropriate keywords. The inclusion criteria for the study were as follows: case-control study, study population consisting of children, study population consisting of young adults, arterial ischemic stroke confirmed by magnetic resonance imaging or computed tomography, and English language. The exclusion criteria included lack of genotype or allele frequencies, study design other than a case-control study, outcome definition other than arterial ischemic stroke, and previously overlapped patient groups. Finally, 30 case-control studies (14 in children and 16 in young adults) were included. Statistical analyses were conducted using R software. Heterogeneity between the studies was evaluated using the Dersimonian and Laird's Q test. In the case of significant between-studies heterogeneity, the pooled odds ratio was estimated with a random-effects model, otherwise a fixed-effects model was used.
The pooled analysis showed that carriers of 20210A allele (GA+AA genotypes) of the prothrombin gene are more common in arterial ischemic stroke patients, both in children and young adults, than in control subjects (P = 0.006; odds ratio, 1.83; 95% confidence interval, 1.19 to 2.80 and P = 0.001; odds ratio, 1.69; 95% confidence interval, 1.25 to 2.28, respectively).
The results of the present meta-analysis have proven that the FII 20210G>A polymorphism is associated with arterial ischemic stroke in both pediatric and young adult patients.
既往数据显示,凝血因子II基因20210G>A多态性与凝血酶原水平升高有关,这可能进而导致促凝状态。动脉缺血性卒中具有异质性和多因素特征,这常常导致不同人群中关于20210G>A多态性与动脉缺血性卒中之间关联的报道相互矛盾。我们对有关凝血因子II 20210G>A多态性与动脉缺血性卒中之间关系的现有数据进行了荟萃分析,涉及青少年和儿童。
我们使用适当的关键词在PubMed上进行检索。纳入本研究的标准如下:病例对照研究、研究人群包括儿童、研究人群包括青少年、经磁共振成像或计算机断层扫描确诊的动脉缺血性卒中以及英文文献。排除标准包括缺乏基因型或等位基因频率、非病例对照研究的研究设计、非动脉缺血性卒中的结局定义以及既往有重叠的患者群体。最终,纳入了30项病例对照研究(14项针对儿童,16项针对青少年)。使用R软件进行统计分析。采用德西蒙尼安和莱尔德Q检验评估研究之间的异质性。若研究间存在显著异质性,则采用随机效应模型估计合并比值比,否则采用固定效应模型。
汇总分析显示,凝血酶原基因20210A等位基因(GA+AA基因型)携带者在动脉缺血性卒中患者中更为常见,在儿童和青少年中均高于对照组(P = 0.006;比值比,1.83;95%置信区间,1.19至2.80;以及P = 0.001;比值比,1.69;95%置信区间,1.25至2.28)。
本荟萃分析结果证明,凝血因子II 20210G>A多态性与儿童和青少年动脉缺血性卒中相关。